Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,763 total articles
Microsoft is a dominant cloud and enterprise software franchise sitting squarely in the path of massive hyperscaler AI capex. Fundamentals remain strong - $3.68T market cap, $67B free cash flow, EPS of $18.01 - and upcoming catalysts (AI deployments, Azure growth, dividend) create a favorable risk/reward for a mid-term position trade. Valuation is …
Rocket Lab (RKLB) just reported record top-line momentum and a $2.36B backlog. With Neutron progressing toward first flight and Space Systems revenue ramping, the stock offers a defined risk-reward swing trade: entry at $80.25, stop at $72.00, target $120.00 over the next 45 trading days.
Faraday Copper offers a high-risk, high-reward way to play a persistent copper deficit and electrification demand. The stock is a speculative buy around current levels with a defined entry, stop, and target. The trade rests on positive drilling news, study progression and financing clarity; failure to hit those milestones or a sustained fall in cop…
Prada's acquisition of Versace and partnerships on smart eyewear have distracted the market from a steadier, underappreciated earnings compounder. At a $13.4B market cap and a mid-teens P/E, Prada offers a pragmatic long trade with a clear stop and defined targets for investors who want exposure to luxury with limited downside.
<p>Nebius is at the center of a structural squeeze in AI compute capacity. Strong quarterly results and a string of strategic partnerships have converted demand pressure into real profitability improvements. The setup is attractive for a disciplined long: the company's platform-centric, asset-light pivot plus large strategic commitments from hypers…
Rollins (ROL) has been punished after a disappointing Q2 and attendant investigations, dragging the shares down to near the 52-week low at $35.98. The core business still generates strong free cash flow ($619M) and high returns on equity (37%), and the balance sheet remains manageable. This trade idea lays out a clear entry, stop and multi-horizon …
1st Source Corp (SRCE) combines conservative capitalization, steady profitability (EPS $7, P/E ~12.6) and a solid free cash flow profile. Asset quality metrics and low debt-to-equity provide downside protection while modest valuation and a 1.8% dividend yield leave room for appreciation. This trade idea sets a clear entry, stop and target across a …
SoFi is firing on many cylinders: membership expansion, cross-sell improving, and revenue growth north of 40%. Market cap sits near $23.6B while valuation metrics look rich, and negative free cash flow plus one underperforming segment keep this a tactical, not core, buy. Trade plan included with entry, stop and target for a 180-trading-day horizon.
Vicor (VICR) is benefitting from AI and data-center demand, but the stock's premium multiples, limited capacity runway, and stretched technicals create a favorable asymmetric short trade in the mid term. Entry $235.76, stop $255.00, target $180.00. Time horizon: mid term (45 trading days).
Natural Grocers (NGVC) is trading below its near-term moving averages after margin pressure and a conservative guide weighed on the stock. The business still shows modest comp growth, a highly penetrated loyalty program and a conservative balance sheet. At roughly $650M market cap and a P/E near 13.4, the downside looks contained while catalysts (D…
Danaher is trading near $203 after a sharp, emotion-driven sell-off in July. Fundamentals remain intact: $5.5B in free cash flow, a manageable debt profile, and improving equipment order momentum. If management can convert acquisitions and delayed consumable shipments into organic growth in 2027, upside to the $240s becomes likely. This trade lays …
KLA (KLAC) plunged from its late-June peak in a broad semiconductor correction. Fundamentals remain intact: high free cash flow ($3.77B trailing), strong returns (ROE 76%), and AI-driven capital spending that underpins equipment demand. Technicals show constructive momentum and a more attractive entry near $204. We recommend a swing trade with an e…
Albemarle ($135.63) is already pricing in a recovery, but with lithium near $20/kg and the company generating roughly $1.34B in free cash flow on a $16B market cap, we see a practical mid-term trade with asymmetric upside. Entry $135.63, target $170.00, stop $118.00 — horizon: mid term (45 trading days).
Zoetis's top-line growth has clearly slowed and the stock has re-rated hard after a string of disappointing Companion Animal updates and related litigation. At roughly $30.6B market cap, a P/E near 12 and P/FCF ~13 leave room for total-return upside if demand stabilizes or the company executes margin leverage. This is a tactical long with controlle…
Boyd Group Services (BYD) is a large, Canada-headquartered consolidator in auto collision repair and related services. After several years of outperformance, shares have softened; we view the current setup as a tactical long opportunity with defined risk controls. Our trade aims to capture reacceleration in organic volumes and margin recovery as in…
ServiceTitan's targeted rollout of Max AI features is already tightening margins while preserving 25%+ top-line growth. The stock has repriced after AI fears, creating a setup where accelerating gross margins and steady free cash flow can drive a re-rating. This trade idea lays out an entry at $90.81, a $118 target and a $78 stop, with a long-term …
Covista (CVSA) combines recurring education revenue, solid free cash flow, and manageable leverage. With the stock trading near $131 and fundamentals showing room for margin upside, a disciplined long trade offers asymmetric reward if enrollment and operating efficiency continue to improve.
Nektar trades near $73.50 after a big run; the imminent commercial development of rezpegaldesleukin (REZPEG) and fresh institutional buying create asymmetric upside vs defined downside. This trade plan targets $95 over the next 45 trading days with a strict $64 stop to respect binary clinical and legal risks.
NexGen Energy sits at the front of the next uranium supply wave. Federal approvals and institutional buying have compressed political and permitting risk; construction execution now becomes the primary moat. This trade idea offers a defined entry at $10.35, a stop at $8.90 and a target at $13.50 over a mid-term 45-trading-day horizon, balancing ups…
ABN AMRO trades around 1.25x book value, offers a constructive mix of earnings resilience and capital flexibility, and looks like a buy for active investors prepared to hold through a couple of quarters of macro noise. We lay out an actionable entry, stop and price target with a 45-trading-day horizon and clear risk controls.
Vicor sits at the junction of two tailwinds: high-density power conversion for AI accelerators and a ramping backlog tied to hyperscalers. Revenue growth and gross margins are strong, but the stock trades at premium multiples. This trade idea offers a measured long exposure with a concrete entry, stop and target tied to capacity execution and topli…
Adicet Bio (ACET) offers a low-cap, high-volatility way to play off-the-shelf gamma delta T-cell therapies. At a market cap ~ $77M and a current price of $8.20, the stock looks inexpensive on book value and enterprise value, but the path to upside hinges on clinical readouts and capital markets activity. This trade lays out an actionable long with …
Salesforce's unprecedented $27 billion buyback has reset the risk/reward profile. The company still generates strong free cash flow, the technical setup is constructive, and short interest has compressed. This trade targets a rebound toward prior resistance, while respecting leverage and execution risk.
ATI has been a standout performer as aerospace and defense activity recovers, but the stock now trades at a premium (P/E ~65, P/B ~16.7) with stretched momentum indicators. I am downgrading my stance and proposing a mid-term short trade: entry $227.80, target $196.00, stop $246.00 — horizon 45 trading days. The thesis rests on valuation mean revers…
Sandisk's investor day introduced aggressive long-term margin and growth targets and disclosed substantial contract visibility. Those details materially change the risk/reward: I upgrade to a tactical long. This trade idea lays out entry, stop, targets, and the key catalysts and risks that will determine whether the upgraded view holds.
